Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report.
Essential thrombocythemia
Platelet
Plateletpheresis
Thrombocytapheresis
Thrombocytosis
Journal
Case reports in oncology
ISSN: 1662-6575
Titre abrégé: Case Rep Oncol
Pays: Switzerland
ID NLM: 101517601
Informations de publication
Date de publication:
Historique:
received:
30
03
2020
accepted:
31
03
2020
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
11
8
2020
Statut:
epublish
Résumé
Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 10
Identifiants
pubmed: 32774255
doi: 10.1159/000507651
pii: cro-0013-0675
pmc: PMC7383192
doi:
Types de publication
Case Reports
Langues
eng
Pagination
675-679Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
J Clin Apher. 2016 Jun;31(3):149-62
pubmed: 27322218
Blood. 2013 Jun 6;121(23):4778-81
pubmed: 23591792
Blood. 2015 Dec 10;126(24):2585-91
pubmed: 26486786
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Am J Med. 2004 Nov 15;117(10):755-61
pubmed: 15541325
Gene. 2019 Mar 20;689:34-42
pubmed: 30553997
Cancer Med. 2020 Jul;9(13):4512-4526
pubmed: 32351024